Feature | March 11, 2010

Hybrid Cath Lab Exhibit at ACC Highlights Growing Trend

March 12, 2010 – In partnership with the American College of Cardiology (ACC), Philips is spotlighting the growing need for hybrid cath labs with a specialty exhibit during ACC 2010 March 14-16 in Atlanta. The need to reduce invasive surgical interventions and complication rates is driving innovations in minimally invasive approaches. Philips and ACC will jointly showcase the Hybrid OR Suite on the expo floor, a solution that combines in one room the equipment needed to perform both open and endovascular cardiac procedures. Built out of combined efforts by Philips and its network of alliances, the Hybrid OR Suite will help advance how clinicians attend to patients in cardiac procedures. Traditionally, X-ray imaging is used to navigate cardiac interventions performed in a cardiac catheterization lab. In recent times, importance has grown for 3D ultrasound imaging in visualizing complex structures during interventions. A hybrid OR suite combines the sterility and instruments of a traditional operating room with the X-ray and ultrasound imaging systems and radiation shields of a cath lab. “Using live 3D TEE ultrasound, we can view the anatomy without incisions or surgery,” said Roberto Lang, M.D., director of noninvasive cardiac imaging labs at the University of Chicago Medical Center. “It provides 3D images unlike those from other technology, to help clinicians place therapeutic devices." The cutting-edge hybrid OR configuration not only provides hospitals with a room that is flexible enough to handle a wide variety of treatments and procedures, but it also helps clinicians from a variety of specialties to collaborate. "Multidisciplinary care is gaining broader acceptance as hospitals and healthcare institutions combine approaches and evolve in their delivery of cardiac care,” said Henry Solomon, M.D., chief medical officer for business development at the American College of Cardiology. “Rooms equipped to support both open surgical and minimally invasive endovascular approaches, such as the hybrid OR, are designed to meet the specific needs of clinicians when they are called upon to perform difficult procedures.” The hybrid OR suite on display at this year’s ACC enables clinicians to perform a full range of endovascular, percutaneous and open procedures. Percutaneous procedures enable physicians to utilize minimally invasive catheter-based interventions to treat patients that may be too sick or frail for open interventions, such as in valve replacement surgery. “The patient is happy, the procedure is less invasive and the collaboration between the cardiologist, the cardiac surgeons and industry—with Philips providing the technology—has made that possible,” said Valluvan Jeevanandam, M.D., chief of cardiac and thoracic surgery at the University of Chicago Medical Center. Philips’ hybrid OR suites are customized for customer needs and designed using an advanced 3D architectural planning tool that provides prospective customers with a visual rendering of possible room configurations. From high-quality, high-resolution, multimodality imaging with advanced 3D software to support confident decision-making, to surgical tables, lighting and other equipment considerations, the full scope of equipment combinations is assessed. The Philips Healthcare booth is 1343, and the Hybrid OR Suite is located in booth 2744. Online visitors can visit http://www.philips.com/media or www.philips.com/hybridor

Related Content

ORSIF, radiation exposure for interventionalists, greater on left side of head, Ehtisham Mahmud
Feature | Radiation Dose Management| October 06, 2015
The results of a research study indicate that interventional cardiologists receive “very high” radiation exposure...
Acutus Medical, AcQMap High Resolution Imaging and Mapping System, improvement over sCT

Image courtesy of Acutus Medical

News | EP Mapping and Imaging Systems| October 06, 2015
Acutus Medical, a global heart rhythm technology company, presented data that show the AcQMap High Resolution Imaging...
Synergy stent
Technology | October 05, 2015
October 5, 2015 — The U.S.
News | Heart Failure| October 02, 2015
Cyberonics Inc. announced results from the extension of the ANTHEM-HF clinical study (ENCORE Study). Results of the...
Tryton Side Branch Stent, clinical trial results, Catheterization and Cardiovascular Interventions

Tryton Side Branch Stent image courtesy of Tryton Medical

News | Stents Bifurcation| October 02, 2015
October 2, 2015 — Tryton Medical Inc.
AtriCure, cryoFORM cryoablation probe, launch
Technology | Ablation Systems| October 02, 2015
AtriCure Inc. launched the cryoFORM cryoablation probe, which offers increased probe flexibility to adapt to a variety...
Brilinta, 60 mg dose available, U.S. pharmacies
Technology | Antiplatelet and Anticoagulation Therapies| October 02, 2015
AstraZeneca announced that Brilinta (ticagrelor) 60-mg tablets are now available in U.S. pharmacies. On Sept. 3, 2015,...
Intact Vascular, TOBA II study, Tack Endovascular System

Image courtesy of Intact Vascular

News | Peripheral Arterial Disease (PAD)| October 01, 2015
Intact Vascular Inc. announced the U.S. Food and Drug Administration has granted conditional approval for a U.S. and...
Cook Medical, Zilver PTX, Japan PMS study, CIRSE 2015, two-year results

Image courtesy of Cook Medical

News | Stents Peripheral| October 01, 2015
Kimihiko Kichikawa, M.D., department of radiology at Nara Medical University in Japan, reported two-year results of the...
Stentys, CE Mark for self-apposing stent, lower limb artery disease, below-the-knee arteries, critical limb ischemia, PES BTK-70 trial

Image courtesy of Stentys

News | Stents Peripheral| October 01, 2015
Stentys announced that the company’s drug-eluting stent received CE Mark for treatment of below-the-knee (BTK) arteries...
Overlay Init